
The global prophylaxis of organ rejection market size was valued at USD 3.30 billion in 2025and is expected to reach USD 4.65 billion by 2033, at a CAGR of 4.40% during the forecast period
The market growth is largely fueled by the rising number of organ transplant procedures worldwide, along with continuous advancements in immunosuppressive therapies and biologic agents, leading to improved graft survival rates and reduced rejection risk across kidney, liver, heart, and lung transplants
.jpg)

